Research Grade Peptide
Antioxidants like vitamin C (citrus fruits, kiwi, strawberries) and selenium (Brazil nuts, tuna) can also help increase glutathione levels
Tesamorelin Recommended for body recomposition Pros Has been shown to selectively reduce abdominal fat in patients with HIV Can also increase muscle area and strength Promising implications for cognitive and cardiovascular health No reported risk of immunogenicity Cons Studies so far have focused on patients with HIV May cause flu-like symptoms Usually administered by subcutaneous injection Prohibited by the World Anti-Doping Agency Tesamorelin is FDA-approved specifically for HIV-associated lipodystrophy excess abdominal lipid accumulation as a result of antiretroviral therapy its efficacy against which was evidenced in a 2010 clinical trial that demonstrated an 18% decrease in visceral fat in intervention subjects compared to placebo.11 Concerning muscle growth, a later study of HIV patients determined that tesamorelin was effective in increasing skeletal muscle area and density.28 Also, because visceral fat is associated with increased cardiovascular mortality, tesamorelin exhibits promise as a treatment for serious health conditions like heart disease and stroke.37 Although tesamorelin studies so far have understandably centered on patients with HIV, theory holds that the peptide should have the same effects on other users
TrustScore 8.31 Make supplements work for you Get the app to see TrustScore details Nutrients Body Protective Compound 500mcg Palmitoylethanolamide 500mg Salcaprozate Sodium 3mg KPV Peptide 500mcg Suggested use: Take 1 capsule daily as a dietary supplement or as directed by your healthcare professional
Common (Oral): Gastrointestinal disturbance, diarrhea, nausea, vomiting, fatigue, conjunctival irritation, skin rash (26) (28) Other: Hypotension, anaphylaxis, asthma attacks, headache (29) Case reports Photosensitivity not attributable to location, season, or concomitant medication: Occurred among pulmonary fibrosis patients more frequently with acetylcysteine than placebo in combination with pirfenidone (39)
